Your browser doesn't support javascript.
loading
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
Salama, Hind Abdin; Jazieh, Abdul Rahman; Alhejazi, Ayman Yahya; Absi, Ahmed; Alshieban, Saeed; Alzahrani, Mohsen; Alaskar, Ahmed; Gmati, Giamal; Damlaj, Moussab; Abuelgasim, Khadega A; Alghamdi, Abdulrahman; Alahmari, Bader; Almugairi, Areej; Alzahrani, Hazza; Bazarbachi, Ali; Musa, M O H; Goyal, Gaurav.
Afiliação
  • Salama HA; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia. Electronic address: salamahe@ngha.med.sa.
  • Jazieh AR; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Alhejazi AY; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Absi A; Section of Adult Hematology and Hematopoietic Stem Cell Transplant, Princess Nora Oncology Centre, King Abdul-Aziz Medical City, Jeddah, Saudi Arabia.
  • Alshieban S; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia; Departments of Pathology and Clinical Laboratory, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia.
  • Alzahrani M; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Alaskar A; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Gmati G; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Damlaj M; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Abuelgasim KA; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Alghamdi A; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia; Department of Clinical Pharmacy, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia.
  • Alahmari B; Department of Oncology, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia.
  • Almugairi A; King Saud bin Abdul-Aziz University for Health Science, College of Medicine, Riyadh, Saudi Arabia; Departments of Pathology and Clinical Laboratory, King Abdul-Aziz Medical City, Riyadh, Saudi Arabia.
  • Alzahrani H; Section of Adult Hematology and Stem Cell Transplant, Department of Oncology, King Faisal Specialist and Research Centre, Riyadh, Saudi Arabia.
  • Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine American University of Beirut, Medical Center, Beirut, Lebanon.
  • Musa MOH; Department of Hematology, Fedail Hospital, Khartoum, Sudan.
  • Goyal G; Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL. Electronic address: ggoyal@uabmc.edu.
Clin Lymphoma Myeloma Leuk ; 21(1): e66-e75, 2021 01.
Article em En | MEDLINE | ID: mdl-32943371
ABSTRACT
Histiocytic disorders are an exceptionally rare group of diseases with diverse manifestations and a paucity of approved treatments, thereby leading to various challenges in their diagnosis and management. With the discovery of novel molecular targets and the incorporation of targeted agents in the management of various adult histiocytic disorders, their management has become increasingly complex. In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis), we created this document based on existing literature and expert opinion.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histiocitose Sinusal / Histiocitose de Células de Langerhans / Doença de Erdheim-Chester / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Diagnostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histiocitose Sinusal / Histiocitose de Células de Langerhans / Doença de Erdheim-Chester / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Diagnostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article